Full Press Release Details
SOURCE: Prima BioMed
May 02, 2012 09:10 ET
Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference
AUSTRALIA (Marketwire May 2, 2012) Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) announced today that Dr. Neil Frazer, Chief Medical Officer, will present at the Deutsche Health Care Conference on Tuesday, May 8, 2012 at 8:40am
Eastern Time in Boston, MA. Dr. Frazer will provide an overview of the Company and its corporate activities.
The presentation will be
webcast live and may be accessed by visiting Prima BioMed s website at http://www.primabiomed.com.au/investor/presentations.php. A replay of the webcast will be available for 10 business days following the presentation.
is a NASDAQ and ASX and listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology.
Prima s lead product is the CVac ovarian cancer therapy treatment. CVac has completed two successful clinical trials and is progressing advanced clinical development in the United States,
Australia, and Europe.
The Company s broader, long term goal is to develop cancer treatment technologies and programs for global
Chief Medical Officer
US Investor Relations
Burns McClellan, Inc
Australia Investor / Media
Investor and Media Relations
Ph: +61 0 420 991 574